LB 11058
LB 11058 is a Cephalosporin Antibacterial agent. LB 11058 inhibits the growth of pathogenic bacteria, including multidrug-resistant staphylococci and streptococci, but shows weak activity against Enterococcus faecium, Corynebacterium species, Enterobacteriaceae and non-fermenting Gram-negative bacilli. LB 11058 can be used in bacterial infection research.
연구목적의 판매만을 진행합니다. 환자를 대상으로 한 판매는 하지 않습니다.
- CAS No.: 591207-81-7
- 화학식: C18H15ClN8O6S3
- 분자량:571.01
-
보관:
Please store the product under the recommended conditions in the Certificate of Analysis.
All Antibiotic Isoforms
More
Biological Activity
제품 설명
In Vitro
LB 11058 (0.008-64 μg/mL) exhibits potent in vitro activity against most tested Gram-positive isolates, with MIC90 values ≤1 μg/mL for β-hemolytic streptococci, penicillin-susceptible/resistant viridans streptococci, Oxacillin (HY-B0925A)-susceptible/resistant S. aureus, Oxacillin-susceptible/resistant coagulase-negative staphylococci (CoNS), vancomycin (HY-B0671)-nonsusceptible staphylococci, and Vancomycin-susceptible/resistant E. faecalis; it shows weak activity against E. faecium, Enterococcus spp., Bacillus spp., and Corynebacterium spp.[1]
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
Chemical Information
-
CAS No. 591207-81-7
-
분자량 571.01
-
화학식 C18H15ClN8O6S3
-
SMILES
OC(C1=C(/C=C/SC2=CC(N=C(N2)N)=O)CS[C@@]([C@@H]3NC(/C(C4=C(SC(N)=N4)Cl)=N\O)=O)([H])N1C3=O)=O
-
선적
Room temperature in continental US; may vary elsewhere.
-
보관
Please store the product under the recommended conditions in the Certificate of Analysis.
Protocol
-
Research Protocol for Infectious Diseases
Infectious-disease experiments test how pathogens interact with host barriers, innate immune receptors, inflammatory signaling, pathogen replication, and tissue injury; pattern-recognition receptors such as TLRs, RIG-I-like receptors, NOD-like receptors, and inflammasomes detect microbial molecules and activate NF-κB, interferon, and cytokine responses. The central hypothesis is that infection severity reflects the balance between pathogen burden and host response: protective inflammation restricts pathogen growth, whereas excessive or mislocalized inflammation contributes to tissue damage and disease phenotype. Unresolved questions include which host pathways are protective versus pathogenic, why some infection models fail to translate to human disease, and which combined readouts best predict clinically relevant infection outcomes.
-
Gram Staining of Tissue Sections
Gram staining of tissue sections is a histochemical technique used to differentiate Gram-positive and Gram-negative bacteria within histological specimens based on differences in bacterial cell wall structure and dye retention, adapted from classical bacteriological Gram staining into tissue-compatible “histological Gram stain” variants. In tissue applications, modifications of the Brown-Hopps and Brown-Brenn methods are commonly used to improve differentiation of microorganisms embedded within host connective tissue and to reduce overstaining or loss of Gram-negative signal, which are known limitations of earlier approaches. The principle relies on crystal violet-iodine complex retention in Gram-positive organisms and subsequent decolorization and counterstaining steps that allow contrast visualization of Gram-negative organisms against tissue background.
순도&문서
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)